Related Experiment Video
Updated: May 28, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Current status of leprosy: epidemiology, basic science and clinical perspectives
Koichi Suzuki1, Takeshi Akama, Akira Kawashima
1Leprosy Research Center, National Institute of Infectious Diseases Department of Dermatology, National Center for Global Health and Medicine, Tokyo, Japan. koichis@nih.go.jp
Leprosy, a chronic infection by Mycobacterium leprae, affects skin and nerves globally, with nearly 250,000 new cases annually. Multidrug therapy reduces prevalence, but ongoing control efforts are crucial.
Area of Science:
- Infectious Diseases
- Immunology
- Dermatology
Background:
- Leprosy is a chronic infectious disease caused by Mycobacterium leprae, affecting millions worldwide.
- It primarily impacts the skin and peripheral nerves, with significant global health implications.
- Annual detection of approximately 250,000 new cases highlights its continued prevalence.
Purpose of the Study:
- To review current understanding of leprosy, including its pathogenesis and clinical manifestations.
- To emphasize the impact of multidrug therapy on disease control.
- To underscore the necessity of sustained leprosy control activities.
Main Methods:
- Review of recent advances in basic science related to leprosy.
- Analysis of the role of cellular immune response variations in clinical presentation.
- Evaluation of the impact of multidrug therapy on leprosy prevalence.
Main Results:
- Advances in basic science have enhanced knowledge of leprosy.
- Cellular immune response variability correlates with diverse clinical manifestations.
- Multidrug therapy has substantially decreased leprosy prevalence.
Conclusions:
- Leprosy remains a significant global health challenge requiring continued attention.
- Understanding the immune response is key to managing its varied clinical presentations.
- Sustained leprosy control programs, including monitoring and prevention, are essential for eradication efforts.
More Related Videos
09:39DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat (VNTR) - Fragment Length Analysis (FLA)
Published on: July 15, 2011
10:37Cultivation Methods of Spirochetes from Borrelia burgdorferi Sensu Lato Complex and Relapsing Fever Borrelia
Published on: November 25, 2022
Related Concept Videos
Leishmaniasis
Infectious Diseases and Their Occurrence
Antiprotozoal Agents
Introduction to Language of Pathophysiology ll
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Introduction to Epidemiology